TIDMFUM

RNS Number : 3971D

Futura Medical PLC

25 June 2019

Director/PDMR Dealings

 
  1   Details of the person discharging managerial responsibilities/person 
       closely associated 
 a)   Name                               James Barder 
     ---------------------------------  -------------------------------------- 
 2    Reason for the notification 
     ------------------------------------------------------------------------- 
 a)   Position/status                    Chief Executive Officer 
     ---------------------------------  -------------------------------------- 
 b)   Initial notification/Amendment     Amendment - additional disclosure 
                                          to the Director Dealing announcement 
                                          dated 19 November 2018 clarifying 
                                          a voluntary surrender of options. 
                                          All other details were and remain 
                                          correct. 
     ---------------------------------  -------------------------------------- 
 3    Details of the issuer, emission allowance market participant, 
       auction platform, auctioneer or auction monitor 
     ------------------------------------------------------------------------- 
 a)   Name                               Futura Medical plc 
     ---------------------------------  -------------------------------------- 
 b)   LEI                                21380053QLT46UNV2303 
     ---------------------------------  -------------------------------------- 
 4    Details of the transaction(s): section to be repeated for (i) 
       each type of instrument; (ii) each type of transaction; (iii) 
       each date; and (iv) each place where transactions have been conducted 
     ------------------------------------------------------------------------- 
 a)   Description of the financial       Ordinary Shares of 0.2 pence each 
       instrument, type of instrument 
 
       Identification code                GB0033278473 
     ---------------------------------  -------------------------------------- 
 b)   Nature of the transaction          Surrender of options over ordinary 
                                          shares 
     ---------------------------------  -------------------------------------- 
 c)   Price(s) and volume(s)              Price(s)   Volume(s) 
                                            61.50      250,000 
                                                     ---------- 
     ---------------------------------  -------------------------------------- 
 d)   Aggregated information             N/A 
       - Aggregated volume 
       - Price 
     ---------------------------------  -------------------------------------- 
 e)   Date of the transaction            16(th) November 2018 
     ---------------------------------  -------------------------------------- 
 f)   Place of the transaction           Outside a trading venue 
     ---------------------------------  --------------------------------------

For further information please contact:

Futura Medical plc

James Barder, Chief Executive

Angela Hildreth, Finance Director and COO

Email: Investor.relations@futuramedical.com

Tel: +44 (0) 1483 685 670

Liberum (Nominated Adviser and Broker)

Bidhi Bhoma

Euan Brown

Kane Collings

Tel: +44 (0) 20 3100 2000

For media enquiries please contact:

Optimum Strategic Communications

Mary Clark/ Hollie Vile/ Ellie Blackwell

Email: futuramedical@optimumcomms.com

Tel: +44 (0) 203 950 9144

Notes to editors:

About Futura Medical plc

Futura Medical plc (AIM: FUM), is a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys(R) drug delivery technology. These products are optimised for clinical efficacy, safety, administration and patient convenience and are developed for the prescription and consumer healthcare markets as appropriate. Current therapeutic areas are sexual health, including erectile dysfunction, and pain relief. Development and commercialisation strategies are designed to maximise product differentiation and value creation whilst minimising risk.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange. www.futuramedical.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHLLFVERRIEFIA

(END) Dow Jones Newswires

June 25, 2019 11:47 ET (15:47 GMT)

Futura Medical (LSE:FUM)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024 Haga Click aquí para más Gráficas Futura Medical.
Futura Medical (LSE:FUM)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024 Haga Click aquí para más Gráficas Futura Medical.